A carregar...
The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer
BACKGROUND: Treatment of locally advanced squamous cell carcinomas of the head and neck (SCCHN) remains unsatisfactory. Although the addition of concurrent radiochemotherapy (RCT) or the combination of radiotherapy with blockade of the epidermal growth factor receptor (EGFR) have improved outcomes o...
Na minha lista:
| Publicado no: | Cancers Head Neck |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6460729/ https://ncbi.nlm.nih.gov/pubmed/31093338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41199-016-0009-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|